Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Apply
Trastuzumab Deruxtecan
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step